Document:

Exhibit 10.1

 

THIS
PROMISSORY NOTE
(THIS “NOTE”)
HAS NOT
BEEN REGISTERED
UNDER THE
SECURITIES ACT OF
1933, AS AMENDED
(THE “ACT”),
APPLICABLE STATE SECURITIES
LAWS, OR
APPLICABLE LAWS
OF ANY
FOREIGN JURISDICTION.
THIS NOTE
HAS BEEN
ACQUIRED FOR
INVESTMENT AND
NOT WITH
A VIEW TO
DISTRIBUTION OR
RESALE, AND
MAY NOT
BE OFFERED,
SOLD, PLEDGED, HYPOTHECATED, RENOUNCED
OR OTHERWISE TRANSFERRED
IN THE ABSENCE
OF AN
EFFECTIVE REGISTRATION
STATEMENT UNDER
THE ACT
AND ANY APPLICABLE
STATE SECURITIES
LAWS AND
IN THE
ABSENCE OF
COMPLIANCE WITH APPLICABLE
LAWS OF ANY
FOREIGN JURISDICTION, OR THE AVAILABILITY OF
AN EXEMPTION FROM
THE REGISTRATION PROVISIONS OF
THE ACT AND
APPLICABLE STATE SECURITIES
LAWS.

 

PROMISSORY
NOTE

	$	2/25/2015

FOR
VALUE RECEIVED,
InterCloud Systems, Inc.,
a Delaware corporation
with a place
of business
at 1030 Broad Street, Suite 102, Shrewsbury, New
Jersey 07702 (“Company”),
promises to pay
to the order
of ___________,
together with
its assignees,
transferees and
successors in
interest (collectively,
“Holder”), in lawful
money of
the United States
of America the
principal sum of
___________ Dollars ($ ), together
with 3% interest per
annum on such principal sum (the “Interest
Rate”). All unpaid principal, together with any accrued and unpaid
interest, and all expenses, fees and other amounts payable hereunder, shall be due and payable on the earliest of: the
Maturity Date, as defined
below or (ii) the date
on which
such amounts are due and payable upon
or after the occurrence of an Event of Default, as defined below, provided that prior to repaying this Note, the Company shall
obtain from Holder the
written statement of
whether Holder chooses to be repaid or waive such
default (in which case the Note would remain outstanding). The Maturity Date for this Note (the “Maturity Date”)
shall initially be January 1, 2018.

 

This Note is
subject to the terms, conditions and
provisions set forth below:

 

1.            
Definitions. As used
in this Note,
the following
capitalized terms
have the following
meanings:

 

“Common
Stock” means
Company’s issued
and outstanding common
stock as registered
under the Securities Act and
traded on any Trading Market.

“Event of Default” has the meaning
given in Section 4 hereof.

 

    	1

    	 

    

 

“Fundamental Transaction” means any transaction or series of related transactions whereby the Company, directly or indirectly, effects a (i) merger or consolidation of the  Company  with  or  into  another  Person,  (ii)  sale,  lease,  license,  assignment,  transfer,
conveyance or other disposition of all or substantially all of its assets, (iii) purchase
offer, tender offer or exchange offer (whether by the Company or another Person) that is completed pursuant to which holders of shares of Common Stock are permitted to sell, tender or exchange their shares for other
securities, cash or property, (iv) reclassification, reorganization
or recapitalization of the Common Stock
or any compulsory share exchange
pursuant to which all outstanding shares of
Common Stock are effectively converted into or exchanged
for other securities, cash or property, or (v) consummation
of the transactions contemplated by a stock or
securities purchase agreement or other business
combination (including, without limitation,
a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person
whereby such other Person acquires more than 50% of the outstanding shares of Common Stock (not including
any shares of Common Stock
held by the other
Person or other Persons
making or party to, or associated or affiliated
with the other Persons making or
party to, such stock or share purchase
agreement or other business
combination).

 

“Maximum Rate” has the
meaning given in Section 2
hereof. 

“New Note”
has the meaning given
in Section 8 hereof.

“Note Register” has
the meaning given in
Section 8 hereof.

“Obligations”
 shall  mean 
and  include 
any  and 
all  loans,  advances, 
debts, liabilities and
obligations, howsoever
arising, owed by
Company to Holder
of every kind
and description (whether
or not evidenced
by any note
or instrument
and whether or
not for the
payment of money), now existing or hereafter
arising under or
pursuant to the terms of this
Note.

 

“Person”
shall mean
and include an
individual, a
partnership, a
corporation (including
a business trust),
a joint stock
company, a
limited liability
company,  an
unincorporated association, a joint venture or other
entity or a governmental authority.

 

“Securities
Act” means the Securities
Act of 1933, as amended.

 

“Trading
Day” means
(i) a day
on which the
Common Stock
is traded
on a
Trading Market, or
(ii) if the
Common Stock
is not quoted
on a Trading
Market, a day
on which the
Common Stock is
quoted in the
over-the-counter market
as reported by
the Pink Sheets,
LLC (or any similar organization
or agency succeeding to its functions of reporting prices).

 

“Trading Market”
means whichever of the New York Stock Exchange, the NYSE AMEX,
the NASDAQ Capital
Market, the NASDAQ
Global Market, the
NASDAQ Global Select Market, or OTC Bulletin
Board on which the Common Stock is listed
or quoted for trading on the date in question.

 

    	2

    	 

    

 

2.             Interest; Maximum Rate.
Interest on this Note shall accrue at the Interest Rate, beginning on the
date hereof, and be
payable upon the Maturity Date. Any amounts not paid when due under this Note shall accrue interest at the rate of 20% per annum until such past due amounts have been paid in full. It is expressly agreed
and provided that the total liability of Company under this Note for payments in the nature of interest shall
not exceed the maximum lawful
rate authorized under applicable law (the “Maximum Rate”), and, without limiting the
foregoing, in no event shall any rate of interest or default interest,
or both of them,
when aggregated with any other sums in the nature of interest that Company
may be obligated to pay under this
Note exceed such Maximum Rate. It is agreed that if the maximum contract rate of interest allowed
by law and applicable to this Note is increased or decreased
by statute or any official governmental
action subsequent to the date hereof, the new maximum
contract rate of interest allowed by
law will be the Maximum Rate
applicable to this Note from the effective
date forward, unless such application is precluded by applicable law. If
under any circumstances whatsoever, interest in excess of the Maximum Rate
is paid by Company to Holder with respect to indebtedness evidenced
by this Note, such excess shall be applied by Holder to all other unpaid
portions of the Obligations or be refunded to
Company at the election of Holder.

 

3.             No Prepayment; Order
of Payments.
This Note may
be prepaid in
full or in
part at
any time
and without
the prior
written consent
of Holder. All
payments received
hereunder shall
be applied
first to the
payment of accrued
interest and any
fees or expenses
payable hereunder and the balance applied
to the unpaid
principal balance then outstanding.

 

4.          
  Events of Default. The occurrence of any of the following shall constitute an “Event
of Default” under this Note:

 

(a)               
Failure to
Pay. Company
shall fail
to pay
when due any
principal, interest, expenses,
fees and other
amounts payable hereunder on
the applicable due date;

 

(b)              
Failure to
Perform.
Company shall fail
to perform
any of its
obligations under this Note when
due;

 

(c)              
Breach. Any of the representations made by
Company in this
Note shall
be false or misleading
in any material respect;

 

(d)              
Change of
Control.
Company (i)
shall initiate
or participate
in any
Fundamental Transactions
or (ii) is
subject to the
acquisition in one
or more
related transactions
by any
Person or
“group” of
Persons (as
such term
is defined
in Section
13(d) and 14(d)
of the Act,
and the
related regulations) who
have expressed
intent to acquire
more than
50% of
the total
voting power of outstanding voting securities
of Company;

 

(e)              
No Listing. Shares
of Common
Stock shall not
be listed or
quoted or are
otherwise suspended from
trading on a
Trading Market for
a period of
five consecutive Trading
Days;

 

(f)              
Voluntary Bankruptcy or
Insolvency Proceedings. Company
shall commence a voluntary
case or other
proceeding seeking
liquidation, reorganization
or other relief
with respect to
itself or its
debts under
any bankruptcy, insolvency
or other similar
law now or
hereafter in effect,
including without limitation,
any assignment
for the benefit
of its creditors
or consent to
any such relief
or to the
appointment of
or taking possession
of its property
by any official
in an involuntary case or
other proceeding commenced against it;

 

(g)               Involuntary Bankruptcy or Insolvency Proceedings. Proceedings for the appointment of a receiver, trustee, liquidator or custodian of Company or of all or a substantial part of the property thereof, or an involuntary case or other proceedings seeking liquidation, reorganization  or  other  relief  with  respect  to  Company  or  the  debts  thereof  under  any
bankruptcy, insolvency or other similar law now or hereafter in effect shall be commenced and an order for relief entered or such proceeding
shall not be dismissed or discharged
within 45 days of commencement.

 

    	3

    	 

    

 

5.    
        Rights of Holder upon Default. Upon the occurrence and during the continuance
of an Event of Default, Holder may, by written notice to Company, declare all outstanding Obligations due hereunder to be immediately due and payable without presentment, demand, protest or any other notice of any kind, all of which are hereby expressly waived. In addition to the foregoing remedies, upon the occurrence of any
Event of Default, Holder may exercise any other right power or remedy permitted to it by law, either by suit in equity or by action at law, or both. Upon the occurrence of any Event of Default, Holder may in its sole discretion choose to waive such default and keep this Note
outstanding pursuant to its
terms herein.

 

6.      
     Note Registration; New Notes for Transfers. Company shall register this Note upon records maintained by Company for that purpose (the “Note Register”) in the name of Holder. Company may deem and treat Holder as the absolute owner hereof for all other purposes, absent actual notice to the contrary from Holder.

 

7.         
   Representations and Warranties of Company. Company represents and warrants to Holder
that:

 

(a)               
Due Incorporation, Qualification,
etc. Company
(i) is a
corporation duly incorporated,
validly existing and
in good standing
under the laws
of the State
of Delaware;

(ii)  
has the power
and authority to
own, lease and
operate its properties
and carry on
its business as
now conducted; and
(iii) is duly
qualified, licensed
to do business
and in good
standing as a
foreign corporation
in each
jurisdiction where
the failure
to be so
qualified or
licensed could
reasonably be expected
to have a
material adverse
effect on the
assets, liabilities,
condition (financial or otherwise)
or business of Company.

 

(a)               
Authority. The execution,
delivery and performance
by Company
of this
Note and the
consummation of
the transactions contemplated
hereby: (i) are
within the
power of Company;
and (ii) have
been duly authorized
by all necessary
actions on the
part of Company.

 

(b)              
Enforceability. This Note
has been duly
executed and delivered
by Company and
constitutes a legal,
valid and binding
obligation of
Company, enforceable
against Company
in accordance
with its terms,
except as limited
by bankruptcy,
insolvency or
other laws
of general application
relating to or
affecting the enforcement
of creditors’
rights generally
and general principles of equity.

 

(c)               
Private Sale. Assuming
that Holder
has purchased
this Note for
investment purposes
and not with
a view to
its distribution,
the issuance
of this
Note does not
require registration under
the Securities Act or
any state securities
laws.

 

(d)              
Issuance of Note.
Neither the
issuance nor
the delivery
of this
Note is subject
to any preemptive
right of any
stockholder of Company
or to any
right of first
refusal or other
similar right in favor
of any person
or entity which
has not been
waived.

 

    	4

    	 

    

 

(e)               
Governmental Approvals.
Company is
not required to
obtain any order,
consent, approval or
authorization of,
or to make
any declaration
or filing with,
any governmental
agency (including under
any state securities
or “blue sky”
laws) in connection
with the
execution and delivery
of this Note,
or the
consummation of
the transactions
contemplated hereby.

 

(f)               
Financial Condition.
Company is
not entering
into the arrangements
contemplated by
this Note
with actual
intent to
hinder, delay or
defraud either present
or future creditors.
On the date
hereof on a
pro forma
basis after giving
effect to the
transactions contemplated
and to all
debts incurred or
to be created
in connection
herewith, the
present fair
salable value
of the assets
of Company (on a
going concern basis)
will exceed the
probable liabilities of
Company on its debts (including its
contingent obligations).

 

8.           
Waiver and Amendment;
Entire Agreement.
No provision
of this
Note may
be amended,
waived or modified
except upon the
written consent
of Company and
Holder. No
failure on the
part of Holder
to exercise,
and no
delay in
exercising, any
right hereunder
shall operate
as a waiver
thereof; nor shall
any single
or partial exercise
of any
right hereunder
by Holder
preclude any other
or further
exercise thereof or
the exercise
of any other
right. This
Note constitutes the
entire agreement
of Company
and Holder with
respect to
the matters
set forth
herein.

 

9.           
Assignment.
Neither this Note
nor any rights
or obligations of
Company hereunder
may be assigned,
conveyed or transferred,
in whole
or in
part other
than as
set forth
in this
Note. The
rights and obligations
of Company
and Holder under
this Note
shall be binding
upon and benefit
their respective
permitted successors,
assigns, heirs,
administrators and
transferees.

 

10.     
    Notices. Any and all notices or other
communications or deliveries hereunder shall be in writing and shall be deemed
given and effective on the earliest of (i)
the date of transmission, if such
notice or communication is delivered via email
to the email address specified in
this Section prior to 5:00 p.m. (New York City time)
on a Trading
Day, (ii) the
next Trading Day after the date
of transmission, if such notice or communication
is delivered via email to the email
address specified in this Section
on a day that is not a
Trading Day or later than 5:00 p.m. (New
York City time) on any Trading Day, (iii) the Trading
Day following the date of mailing, if sent
by nationally recognized overnight courier service or (iv) upon
actual receipt by
the party to
whom such notice is required to be given. The addresses
for such communications shall be: (i) if to Company,
to InterCloud Systems, Inc., 1030 Broad Street, Shrewsbury, NJ 07702,
Attention: Timothy A. Larkin, email
address: tlarkin@intercloudsys.com, and (ii) if to Holder,
to the address or email
address appearing on Company’s
shareholder records or Note
Register or such
other address as Holder may provide
to Company in accordance with this
Section 14, with a mandatory
copy of any
notice to Holder
not sent by email to be simultaneously
emailed to the email address of
Holder appearing on the Company’s Note Register
with a simultaneous cc
by email to:mfdurfee@gmail.com.

 

11.       
   Fees and Expenses. Company agrees to pay to Holder, in addition to the principal amount due hereunder, all fees and expenses (including court costs and legal fees and
expenses) incurred or expended by Holder in connection with the negotiation, administration and enforcement
of this Note.

 

    	5

    	 

    

 

12.           Waiver
of Jury
Trial. COMPANY,
AFTER CONSULTING
OR HAVING
HAD THE
OPPORTUNITY TO
CONSULT WITH
COUNSEL, KNOWINGLY,
VOLUNTARILY AND
INTENTIONALLY HEREBY
IRREVOCABLY WAIVES
ITS RIGHT
TO A
TRIAL BY
JURY IN
ANY ACTION ARISING OUT
OF THIS NOTE
AND THE TRANSACTIONS
CONTEMPLATED HEREUNDER.

 

13.           Headings. The headings
herein are for
convenience only, do
not constitute
a part of
this Note and
shall not be
deemed to limit or affect
any of the
provisions hereof

 

14.         
 Severability.
If one or
more provisions
of this Note
are held to
be unenforceable under
applicable law, such
provision(s) shall
be excluded
from this
Note and
the balance
of the
Note shall be
interpreted as if
such provision(s)
were so excluded
and shall be
enforceable in
accordance with its
terms.

 

15.           Governing
Law; Jurisdiction.
The provisions of
this Note shall
be governed by
and construed
in accordance
with the
laws of
the State of
New Jersey without
reference to conflict
of law provisions.
Any action or
proceeding in connection
with this Agreement
shall be brought
in any court
of record of
the State of
New Jersey or
the United States
in such state,
and the parties
hereto irrevocably consent
to and confer
personal jurisdiction of
such court over
them by such court.

 

 

Signatures
appear on the
following page

 

 

    	6

    	 

    

 

IN
WITNESS
WHEREOF, the
Company has
caused this Note
to be issued
as of the
date first written
above.

 

	 	INTERCLOUD SYSTEMS, INC.
	 	 	 
	 	By: 	 
	 	Name 	 
	 	TitleEX-4.4

 Exhibit 4.4 

VASCULAR BIOGENICS LTD. 

(the “Company”) 

AMENDED AND RESTATED 

EMPLOYEE SHARE OWNERSHIP 

AND OPTION PLAN (2000) 

 TABLE OF CONTENTS 

 

					
	1.		 Preamble.
		
			
	2.		 Administration of the Plan.
		
			
	3.		 Shares Subject to the Plan.
		
			
	4.		 Option Exercise Prices.
		
			
	5.		 Exclusivity of the Plan.
		
			
	6.		 Grant of the Options and Issuance of the Shares to the Trustee.
		
			
	7.		 Option or Share Purchase Agreement; Termination of Employment.
		
			
	8.		 Acceleration of an Option.
		
			
	9.		 Term of Options; Exercise.
		
			
	10.		 Additional Documents.
		
			
	11.		 Taxation.
		
			
	12.		 Dividends.
		

					
			
	13.		 Rights and/or Benefits arising out of the Employee/Employer Relationship and the Absence of an Obligation to Employ.
		
			
	14.		 Adjustments Upon Changes in Capitalization.
		
			
	15.		 Term, Termination and Amendment.
		
			
	16.		 Effectiveness of the Plan.
		
			
	17.		 Release of the Trustee and the Attorney from Liability and Indemnification.
		
			
	18.		 Governing Law.
		

 APPENDICES 
  

			
	Appendix A:		Employee’s Notice to the Trustee as to Exercise of the Option (Section 9.2).
		
	Appendix B:		Notice to the Company of Exercise of the Option by the Trustee (Section 9.4).
		
	Appendix C and D:		Proxy and Power of Attorney (Section 10.2).

	1.	PREAMBLE 

  

	 	1.1	This plan, as amended from time to time, shall be known as the “Vascular Biogenics Ltd. Employee Share Ownership and Option Plan (2000)” (the “Plan”). The purpose and intent of the Plan is to
provide incentives to employees, directors, service providers and/or advisors of the Company, the parent and/or of subsidiaries and/or of affiliated companies of the Company (each a “Related Company” and collectively,
“Related Companies”) by providing them with the opportunity to purchase shares of the Company. 

 The Plan is
designed to comply with Section 102 of the Israeli Income Tax Ordinance (New Version), 1961, as amended from time to time, or any provision which may amend or replace it (the “Ordinance” and “Section 102”) and
the rules, regulations and orders or procedures promulgated thereunder from time to time, as amended or replaced from time to time (the “Rules”) and to enable the Company and grantees hereunder to benefit from Section 102 and
the Rules and also to enable the Company to grant options and issue shares outside the context of Section 102. The Company, however, does not warrant that the Plan will be recognized by the income tax authorities or that future changes will not
be made to the provisions of the law, regulations or the Rules, which are promulgated from time to time, or that any exemption or benefit currently available pursuant to Section 102 will not be abolished. 

 

	 	1.2	Should any provision of Section 102, regulations thereunder or the Rules which applies to employees be amended, such amendment shall be deemed included in the Plan with respect to options granted or shares issued
in the context of Section 102. Where a conflict arises between any section of the Plan, the Agreement (as defined in Section 7 below) or their application, and the provisions of the law and the Rules, the Board of Directors of the Company
(the “Board”) in its sole discretion shall determine the necessary changes to be made to the Plan and their determination regarding this matter shall be final and binding. 

 

	 	1.3	In the event the Company’s shares should be registered for trading on the Tel-Aviv Stock Exchange Ltd. or on any other stock exchange, whether in Israel or abroad, the options and/or shares allotted in accordance
with the Plan may be made conditional to any requirement or instruction of the stock exchange authorities or of any other relevant authority acting pursuant to applicable law as shall exist from time to time. In such case, by means of a Board
resolution, the Plan and the agreements prepared pursuant hereto, may be amended as necessary to meet such requirements. In the event of a contradiction between any such amendment and the Plan’s provisions, the amendment shall prevail.

	2.	ADMINISTRATION OF THE PLAN 

  

	 	2.1	The Plan shall be administered by the Board and/or by any committee of the Board so designated by the Board. Any subsequent references herein to the Board shall also mean any such committee if appointed and, unless the
powers of the committee have been specifically limited by law or otherwise, such committee shall have all of the powers of the Board granted herein. Subject to Sections 4 and 15 and applicable law, the Board shall have plenary authority to determine
the terms and conditions of all options (which need not be identical), including, without limitation, the purchase price of the shares covered by each option, the individuals to whom, and the time or times at which, options shall be granted, the
number of shares to be subject to each option, whether or not an option shall be granted pursuant to Section 102 , and if so, whether such option be granted to a trustee under the Ordinance and the election of the “Work Income Route”
according to Section 102(b)(1) of the Ordinance or the “Capital Gains Route” according to Section 102(b)(2) of the Ordinance or otherwise, and when an option can be exercised and whether in whole or in installments. Subject to
Section 15, the Board shall have plenary authority to construe and interpret the Plan, to prescribe, amend and rescind the rules and regulations relating to it and to make all other determinations deemed necessary or advisable for the
administration of the Plan. All determinations and decisions of the Board pursuant to the provisions of the Plan and all related orders and resolutions of the Board shall be final, conclusive and binding on all persons, including the Company, its
shareholders, grantees and their estates and beneficiaries. 

  

	 	2.2	Any directive or notice signed by two members of the Board shall constitute conclusive proof and authority for every act or decision of the Company. 

 

	 	2.3	No director or officer of the Company shall be personally liable or obligated to any grantee as a result of any decision made and/or action taken with respect to the Plan or its execution. 

 

	3.	SHARES SUBJECT TO THE PLAN 

 The shares subject to the Plan shall be Ordinary
Shares of the Company. The maximum number of shares that may be issued under the Plan is 46,846 Ordinary Shares of NIS 0.01 nominal value each, as such number of shares may be adjusted in accordance with Section 14. Such shares may be in whole
or in part, as the Board shall from time to time determine and subject to applicable law, authorized and unissued Ordinary Shares or issued and fully paid Ordinary Shares which shall have been purchased by the trustee hereunder with funds provided
by the Company. If any option granted under the Plan shall expire, terminate or be canceled for any reason without having been exercised in full, such shares subject thereto shall again be available for the purposes of the Plan. Any increase in the
maximum number of shares shall be recommended by the Board and shall require the approval of the general meeting of the shareholders of the Company. 

	4.	OPTION EXERCISE PRICES 

 The consideration to be paid by a grantee for each share
purchased by exercising an option (the “Option Exercise Price”) shall be as determined by the Board on the date of grant, provided that the Option Exercise Price shall not be less than the nominal value of the shares subject to the
option. 
  

	5.	EXCLUSIVITY OF THE PLAN 

 Unless otherwise determined by the Board in any
particular instance as part of the Agreement, each grantee hereunder will be required to declare and agree that all prior agreements, arrangements and/or understandings with respect to shares of the Company or options to purchase shares of the
Company which have not actually been issued or granted prior to execution of the Agreement shall be null and void and that only the provisions of the Plan and/or the Agreement shall apply. 

Notwithstanding the above, the adoption of this Plan, by itself, shall not be construed as amending, modifying or rescinding any incentive
arrangement previously approved by the Board or as creating any limitations on the power of the Board to adopt such other incentive arrangements as it may deem desirable, including, without limitation, the granting of options otherwise than under
this Plan, and such arrangements may be either applicable generally or only in specific cases. 
  

	6.	GRANT OF THE OPTIONS AND ISSUANCE OF THE SHARES TO THE TRUSTEE; VOTING OF SHARES 

  

	 	6.1	Shares issued upon exercise of an option shall be issued to the grantee or to the Trustee (as such term is defined below), in the name of the grantee and on his or her behalf, subject to the sole discretion of the
Board. In the event the Board grants an option to be held by the grantee upon exercise, all rights conveyed to the Trustee according to this Plan shall be awarded to the said grantee. 

	 	6.2	The Board shall appoint a Trustee for the purposes of this Plan (the “Trustee”). The Trustee shall have all the powers provided by law, the Rules, the trust agreement with the Company and the Plan and
shall act pursuant to the provisions thereof, as they shall apply from time to time. The Company shall pay the Trustee a fee as shall be agreed between the Trustee and the Company. 

 

	 	6.3	Unless otherwise determined by the Board, all option awards shall be issued by the Company in the name of the Trustee and the share certificates representing any shares issued pursuant to options exercised hereunder,
shall be issued by the Company in the name of the Trustee in trust for the designated grantee and shall be deposited with the Trustee, held by him and registered in his name in the register of members of the Company for such period as determined by
the Board but, in the case of grants pursuant to Section 102, not less than the period set forth therein or otherwise required, or approved, with respect thereto pursuant to Israeli law, regulations promulgated thereunder or the Rules, as shall
be in effect from time to time (hereinafter the “Restriction Period”). 

  

	 	6.4	Without derogating from the provisions of Sections 6.3 above or 6.7 below, and unless otherwise determined by the Board generally or in any particular instance, the shares issued with respect to any options granted
hereunder will be held by the Trustee and registered in his name until the earlier of consummation of the initial public offering of the Company’s shares, pursuant to an effective registration statement, prospectus or similar document in Israel
or such other jurisdiction as is determined by the Board (the “IPO”) or 10 years from the date of their issue, after which time the grantee for whom they are being held may request their registration in his name and transfer to him
subject to the provisions of Section 102, regulations thereunder of the Rules and the Plan all as shall be in effect from time to time (e.g., payment of taxes, etc.). After the consummation of the IPO, options granted pursuant to
Section 102 will be held by the Trustee and registered in his name in trust for the designated grantee, for not less than the period required or approved with respect thereto pursuant to Israeli law, regulations promulgated thereunder or the
Rules, as shall be in effect from time to time. 

  

	 	6.5	Options granted hereunder shall not confer upon the holder thereof any of the rights of a shareholder of the Company, for as long as it has not been exercised and, once exercised, for as long as the shares have not been
issued, transferred and registered in the grantee’s name in the Company’s register of members. 

 6.6. For as long as
any shares are held by the Trustee or registered in his name or for as long as the certificates representing any shares are held by the Trustee, the Trustee alone shall be entitled to receive every notice to which a shareholder is entitled, or to
demand any information, and any financial and/or other report to which a shareholder is entitled from the Company, and only he or whomever he shall designate pursuant to the Proxy and Power of Attorney referred to in Section 10.2

 
below and attached as Appendix C hereto (the “Attorney”), shall be entitled to exercise every other right of the shareholders vis-a-vis the Company not including the right
to participate and vote (or abstain) on all matters at all shareholders’ meetings (whether ordinary or extraordinary) and the right to sign any resolution in writing in the name of the shareholders. 

The Attorney shall appoint the proxy of the shareholders to participate and vote (or abstain) on all matters at all meetings of shareholders
(whether ordinary, extraordinary or otherwise), and to sign any resolution in writing in the name of the shares held by the Trustee in the form attached hereto as Appendix D. Initially Dr. Dror Harats shall be appointed as the Proxy to
all meetings. 
  

	 	6.7	Shares registered in the Trustee’s name shall be represented at all meetings of shareholders of the Company and, until consummation of the IPO, shall be shall be voted by the Proxy at his discretion in the best
interests of the Company and following the consummation of an IPO in accordance with the instructions of the grantees on whose behalf they are held and in the absence of such instructions they shall abstain. 

 

	 	6.8	Nothing in the aforegoing provisions shall derogate from the power of the Board to grant options or to allot shares to the Trustee otherwise than under the provisions of Section 102 and the Rules or to allot shares
or grant options to grantees directly otherwise than through the Trustee or on terms which differ from those specified above or to approve the transfer of shares from the Trustee to the name of any grantee(s) upon such conditions as shall be
determined by the Board. 

  

	7.	OPTION OR SHARE PURCHASE AGREEMENT; TERMINATION OF EMPLOYMENT 

 Unless otherwise
determined by the Board, every grantee shall be required to sign an option or share purchase agreement or other document as shall be determined by the Board, in the form approved by the Board (the “Agreement”). 

The Agreement need not be identical with respect to each grantee. The following terms, however, shall apply to all options, and, mutatis
mutandis, shares, unless expressly otherwise decided in respect of a particular option: 
  

	 	7.1	In addition to the provisions of Section 4 and without prejudice thereto, where the law and the Rules apply to the Agreement and so require, the option shall be granted to the grantee in consideration for a waiver
of salary by the grantee pursuant to the provisions of the Agreement. 

	 	7.2	The Option Exercise Price shall be paid by the grantee to the Company no later than the date of exercise of the option unless otherwise determined in the Agreement. 

 

	 	7.3	The grantee shall have no right of first refusal to purchase shares of the Company which may be offered for sale by shareholders of the Company, and shall have no pre-emptive rights to purchase shares which are being
allotted or shall in the future be allotted by the Company, to the extent any such rights otherwise exist. 

  

	 	7.4	The option and/or the right to the option and/or the shares are personal and except insofar as is specified in this Plan, and, where applicable, subject to Section 102 and the Rules, may not be transferred,
assigned, pledged, withheld, attached or otherwise charged either voluntarily or pursuant to any law, except by way of transfer pursuant to the laws of inheritance, and no power of attorney or deed of transfer, whether the same has immediate effect
or shall take effect on a future date, shall be given with respect thereto. During the lifetime of the grantee the option may only be exercised by the designated grantee or, if granted to the Trustee, by the Trustee on behalf of the designated
grantee. A note as to the provisions of this sub-section or a legend may appear on any document which grants the option and in particular in the Agreement, and also on any share certificate. 

 

	 	7.5	The right to exercise the option is granted to the Trustee on behalf of the grantee. Vesting shall be in installments, gradually over a period of 4 (four) years from the date of grant of the option or such other period
or periods as determined by the Board. Unless otherwise determined, at the conclusion of each period for the exercise of the option as determined in the Agreement (“Vesting Periods”), the option may, from time to time, be exercised
in relation to all the shares allocated for that period in such manner that at the end of the 2 (two) years from the granting of the option the Trustee shall, in the absence of a contrary determination in the Agreement, be entitled to exercise on
behalf of the grantee and at his request  1⁄2 (half) of the options and at the end of each of the remaining 2 (two) years another
 1⁄4 (quarter), provided that, unless otherwise determined by the Board, upon each of such vesting dates the grantee continues to be employed by, or provide
services to, the Company or a Related Company on a continual basis from the date of the grant thereof. 

 In addition, during
each of the Vesting Periods, the option may be exercised in relation to all or part of the shares allocated for any previous Vesting Period in which the option was not fully exercised, provided, subject to the provisions of Section 7.7 hereof,
that at the time of the exercise of the option the grantee has continued to be employed by the Company or a Related Company on a continual basis from the date of the grant thereof until the date of their exercise. After the end of

 
the Vesting Periods and during the balance of the option period, the option may be exercised, from time to time, in relation to all or part of the shares which have not at that time been
exercised and which remain subject to the option, subject to the provisions of Section 7.7 hereof and to any condition in the Agreement, if such exists, which provides a minimum number of shares with respect to which the option may be exercised
and any provision which determines the number of times that the Trustee may send the Company notice of exercise on behalf of the grantee in respect of the option. The Board shall be entitled at any time to shorten the vesting schedule or any Vesting
Period. 
  

	 	7.6	The Board may determine at its sole discretion, that any grantee shall be entitled to receive the options or the shares, through the Trustee, pursuant to the provisions of this Plan or directly in the name of the
grantee, immediately upon execution of the Agreement or on such other date or dates as the Company has undertaken towards such grantee. In the event that a grantee is exempt from the Vesting Periods (pursuant to the provisions of Section 7.5),
the Board shall be entitled, subject to applicable law, to determine that where the grantee does not comply with the conditions determined by the Board or ceases to be an employee of the Company or a Related Company, the Trustee, the Company or a
Related Company shall have the right to repurchase the shares from the grantee for nominal or any other consideration paid by the grantee. The Board may set additional conditions to this right of repurchase, including the provision of appropriate
arrangements for the monies which shall be available to the Trustee or a Related Company or others for the purpose of the repurchase and conditions with respect to the voting rights of the grantee, rights of first refusal or pre-emptive rights to
purchase shares in the Company, to the extent such rights exist, the grantees right to receive reports or information from the Company, and the grantee’s right to a dividend in respect of shares which are subject to a right of reacquisition as
aforesaid. For as long as the aforegoing conditions of the Board (including a minimum period of employment as a condition for the lapse of the right to reacquisition) have not been complied with, the grantee shall not be entitled to sell or charge
or transfer in any other manner the shares which are subject to the right of reacquisition. As security for the compliance with this undertaking the share certificate will be deposited with the Trustee who will release the same to the grantee only
after the grantee becomes entitled to the shares and the same are not subject to any other restrictive condition. 

  

	 	7.7	Termination of Employment 

  

	 	7.7.1	 If the employment of a grantee is terminated prior to the complete exercise of an option, (a) by reason of death, disability (as determined by
the Board in its absolute discretion) or retirement after age 60 with the approval of the Board, the option shall remain exercisable for a period of one year following such termination (but only to the extent exercisable at termination of employment
and not beyond the scheduled expiration date); and (b) for any other reason other than for Cause, the option shall remain exercisable for a period of 

	 	
ninety (90) days following the earlier of such termination or notice of termination (but only to the extent exercisable at the earlier of termination or notice of termination of employment
and not beyond the scheduled expiration date) (unless the Agreement provides otherwise); or (c) for Cause, as such term is defined below, all options held by or on behalf of such grantee shall immediately expire upon the earlier of such
termination or notice of termination (unless the Agreement provides otherwise). 

 For purposes hereof, the term
“Cause” shall mean any of (i) a material breach by the grantee of the grantee’s obligations under any agreement with the Company or any Related Company; (ii) the commission by the grantee of an act of fraud or
embezzlement against the Company or any Related Company or the willful taking of action injurious to the business or prospects of the Company or any Related Company; (iii) the conviction of the grantee of a felony; and (iv) the
grantee’s involvement with an act which constitutes breach of trust between the grantee and the Company or any Related Company. 
 The
Board may determine whether any given leave of absence constitutes a termination of employment. Options awarded under this Plan shall not be affected by any change of employment so long as the grantee continues to be an employee of the Company or a
Related Company. 
  

	 	7.7.2	In such case as Section 102 and the Rules shall apply to any option, where the grantee ceases to be an employee of the Company prior to the termination of such period as may be prescribed by applicable law,
regulations or the Rules, the exemption provided by Section 102 shall not apply with respect to that grantee pursuant to the Rules. In such case, the grantee shall be obliged to make arrangements with the tax authorities at his expense for all
matters to do with the taxation of the options and/or the shares. 

  

	 	7.7.3	Notwithstanding the foregoing, the Board may in its absolute discretion, extend the period of exercise of the option by a grantee or grantees for such time as it shall determine either with or without conditions.

  

	8.	ACCELERATION OF AN OPTION 

 If an event described in item (c) of the
definition of a Significant Event (as defined below) shall occur then, notwithstanding any contrary Vesting Periods in any Agreement or in this Plan, and unless in each case the applicable Agreement provides otherwise, one-half (1/2) of the
outstanding options held by or for the benefit of any grantee and which have not yet vested shall be accelerated and become immediately vested and exercisable. 

 Furthermore, if an event described in items (a) and (b) of the definition of a
“Significant Event”, defined below, shall occur, and either (i) the employment of a grantee with the Company or a Related Company is terminated by the Company or a Related Company within twelve (12) months thereafter (other than
for Cause), (ii) a grantee resigns his employment with the Company or with a Related Company within such period due to an adverse change in his position with the Company or a Related Company (as defined in his employment agreement) or in
circumstances which would result in such resignation being deemed termination by the Company or a Related Company pursuant to Section 11(a) of the Severance Pay Law, 1963; or (iii) the surviving corporation in a consolidation or merger,
referred to in (a) below under Significant Event, does not assume the option or substitute it with an appropriate option in the surviving corporation; and unless in each case the applicable Agreement provides otherwise, all outstanding options
held by or for the benefit of any such grantee and which have not yet vested shall be accelerated and become immediately fully vested and exercisable in full (notwithstanding any contrary vesting schedule previously agreed). 

Each of the following shall be a “Significant Event”: approval by the Board or (if approval of the shareholders is required)
shareholder approval of: (a) any consolidation or merger of the Company in which the Company is not the continuing or surviving corporation or pursuant to which Ordinary Shares would be converted into cash, securities or other property, other
than a merger of the Company in which the holders of Ordinary Shares (on an as converted basis) immediately prior to the merger have the same proportionate ownership of Ordinary Shares (on an as converted basis) of the surviving corporation
immediately after the merger; or (b) any sale, lease, exchange or other transfer (in one transaction or a series of related transactions) of all or substantially all the assets or all or substantially all of the outstanding and issued shares of
the Company; or (c) the adoption of any plan or proposal for the liquidation or dissolution of the Company. In addition, effective from consummation of the IPO, each of the following shall also be considered a “Significant
Event”: any person or group other than the Company making a tender offer or exchange offer to acquire any Ordinary Shares (or securities convertible into Ordinary Shares) for cash, securities or any other consideration, provided that
: (y) at least a portion of such securities sought pursuant to the offer in question is acquired; and (z) after consummation of such offer, the person in question is the beneficial owner, directly or indirectly, of 20% or more of the
outstanding Ordinary Shares; or (iii) during any period of two consecutive years, individuals who at the beginning of such period constituted the entire Board ceasing for any reason to constitute a majority thereof unless the election, or the
nomination for election by the Company’s shareholders, of each new director was approved by a vote of at least two-thirds of the directors then still in office who were directors at the beginning of the period. 

	9.	TERM OF OPTIONS; EXERCISE 

  

	 	9.1	The term of each option shall be for such period as the Board shall determine, but not more than 10 (ten) years from the date of grant thereof or such shorter period as is prescribed in Section 7.7 hereof.

  

	 	9.2	A grantee who desires that the Trustee exercise an option granted to the Trustee on his behalf shall so instruct the Trustee in writing in the form annexed hereto as Appendix A or in such other form as shall be
approved by the Board. The notice shall be accompanied by payment of the full Option Exercise Price of such shares as provided in the Agreement. 

  

	 	9.3	As a condition for the exercise of the option, the grantee shall pay the tax applicable to him (including all tax payable by the Company arising out of its obligation to deduct tax at source) pursuant to applicable law
and the provisions of the Plan. 

  

	 	9.4	Upon receipt of all the requisite documents, approvals and payments from the grantee, including sufficient proof of payment or other arrangement with respect to the payment of any applicable taxes in form satisfactory
to the Company and the Trustee, the Trustee shall deliver a notice to the Company in the form annexed hereto as Appendix B or in such other form as shall be approved by the Board, whereupon the Company shall allot the shares in the name of
the Trustee. 

  

	 	9.5	A grantee who desires to exercise an option granted directly to him (and not through the Trustee) shall so notify the Company in writing in such form as shall be prescribed by the Board from time to time. As a condition
for the exercise of the option, the grantee shall pay or otherwise make arrangements, to the Company’s satisfaction, for the payment of the tax applicable to him (including all tax payable by the Company arising out of its obligation to deduct
tax at source) pursuant to applicable law and the provisions of the Plan. Upon receipt of all the requisite documents, approvals and payments from the grantee, including sufficient proof of payment or other arrangement with respect to the payment of
any applicable taxes in form satisfactory to the Company, the Company shall allot the shares in the name of the grantee. 

  

	 	9.6	Without limiting the foregoing, the Board may, with the consent of the grantee, from time to time cancel all or any portion of any option then subject to exercise, and the Company’s obligation in respect of such
option may be discharged by: (i) payment to the grantee or to the trustee on behalf of the grantee of an amount in cash equal to the excess, if any, of the Fair Market Value of the relevant shares at the date of such cancellation subject to the
portion of the option so canceled over the aggregate Option Exercise Price of such shares; (ii) the issuance or transfer to the grantee or to the trustee on behalf of the grantee of shares of the Company with a Fair Market Value at the date of
such transfer equal to any such excess; or (iii) a combination of cash and shares with a combined value equal to any such excess, all as determined by the Board in its sole discretion. 

 For purposes hereof, the “Fair Market Value” of the Ordinary Shares shall mean, as of
any date, the last reported sale price, on that date, of the Ordinary Shares of the Company on the principal securities exchange on which such shares are then traded, or, in the event that no sales of such shares took place on such date, the last
reported sale price of such shares on such principal securities exchange on the most recent prior date on which a sale of shares took place; provided, however, that if such shares are not publicly traded on the date as of which Fair Market Value is
to be determined, “Fair Market Value” of the Ordinary Shares shall mean the value as determined in good faith by the Board. 
  

	10.	ADDITIONAL DOCUMENTS 

  

	 	10.1	Until the consummation of the IPO, the Company shall have the right to demand from the grantee at any time that the same shall provide, and the grantee shall provide, any certificate, declaration or other document which
the Company and the Trustee shall consider to be necessary or desirable pursuant to any law, whether local or foreign, including any undertaking on the part of the grantee not to sell his or her shares during any period which shall be required by an
underwriter or investment bank or advisor of the Company for the purpose of any share issue whether private or public and including any certificate or agreement which the Company shall require, if any, from the grantees as members of a class of
shareholders, or any certificate, declaration or other document the obtaining of which shall be deemed by the Board and the Trustee to be appropriate or necessary for the purpose of raising capital for the Company, of merging the Company with
another company (whether the Company is the surviving entity or not), or of reorganization of the Company, including, in the event of a consolidation or merger of the Company or any sale, lease, exchange or other transfer of all or substantially all
of the assets or shares of the Company the sale or exchange, as the case may be, of any shares the grantee (or the Trustee on his behalf) may have purchased hereunder all as shall be deemed necessary or desirable by the Board and the Trustee.

  

	 	10.2	In order to guarantee the aforesaid, and because the rights of the Company and the other shareholders are dependent thereon, the grantee shall, upon signing the Agreement and as a condition to the grant of any options
hereunder, execute the Proxy and Power of Attorney attached hereto as Appendix C and D, or in such other form as shall be approved by the Board, irrevocably empowering the Trustee and/or the Attorney, until consummation of the IPO, to
sign any document and take any action in his name as aforesaid, and the grantee shall have no complaint or claim against the Trustee and/or the Attorney in respect of any such signature or action, or in respect of any determination of the Trustee
pursuant hereto or to Section 10.1 above. The grantee will authenticate his signature in the presence of a notary if he shall be asked to do so by the Company, in order to give full validity to the power of attorney. 

	11.	TAXATION 

  

	 	11.1	General 

 The grantee shall be liable for all taxes, duties, fines and other payments
which may be imposed by the tax authorities (whether in Israel or abroad) and for every obligatory payment of whatever source in respect of the options, the shares (including, without limitation, upon the exercise of the options, the sale of the
shares or the registration of the shares in the grantee’s name) or dividends or any other benefit in respect thereof and/or for all charges which shall accrue to the grantee, the Company, any Related Company and/or to the Trustee in connection
with the Plan. 
  

	 	11.2	Deduction at Source 

 The Company (including any Related Company) and/or the Trustee
shall have the right to require the grantee to pay an amount in cash or to retain or sell without notice Ordinary Shares in value sufficient to cover any tax required by an governmental entity to be withheld or otherwise deducted and paid with
respect to the options or the Ordinary Shares subject thereto (including, without limitation, upon their exercise or sale or the registration of the Ordinary Shares in the grantee’s name) or with respect to dividends or any other benefits in
respect thereof (“Withholding Tax”), and to make payment (or to reimburse itself or himself for payment made) to the appropriate tax authority of an amount in cash equal to the amount of such Withholding Tax. Notwithstanding the
foregoing, the grantee shall be entitled to satisfy the obligation to pay any Withholding Tax, in whole or in part, by providing the Company and/or the Trustee with funds sufficient to enable the Company and/or the Trustee to pay such Withholding
Tax. 
  

	 	11.3	Certificate of Authorization of Assessing Officer 

 The Company (including any Related
Company) or the Trustee shall at any time be entitled to apply to the Assessing Officer, and in the case of a grantee abroad, to any foreign tax authority, for receipt of their certificate of authorization as to the amount of tax which the Company
or any Related Company or the grantee or the Trustee is to pay to the tax authorities resulting from granting the options or allotting the shares, or regarding any other question with respect to the application of the Plan. 

	12.	DIVIDENDS 

 The Ordinary Shares issued as a result of the exercise of the options
shall participate equally with the Company’s other Ordinary Shares in every cash dividend which shall be declared and distributed subject to the following provisions: 
  

	 	12.1	A cash dividend shall be distributed only to persons registered in the register of members as shareholders on the record date fixed for the distribution of the dividend. 

 

	 	12.2	A dividend with regard to shares which are registered in the name of the Trustee shall be paid to the Trustee, subject to any lawful deduction of tax, whether such rate is at the usual rate applicable to a dividend or
at a higher rate. The Trustee shall transfer the dividend to the grantee in accordance with instructions that he shall receive from the Company. Alternatively, the Company shall be entitled to pay the dividend directly to the grantee subject to the
deduction of the applicable tax. 

  

	 	12.3	Without derogating from the provisions of Section 12.2 hereof, the Company or the Trustee shall be entitled to set off and deduct at source from any dividend any sum that the grantee owes to the Company (including
any Related Company) or the Trustee, whether under the Plan or otherwise, and/or any sum that the grantee owes to the tax authorities. 

  

	13.	RIGHTS AND/OR BENEFITS ARISING OUT OF THE EMPLOYEE/ EMPLOYER RELATIONSHIP AND THE ABSENCE OF AN OBLIGATION TO EMPLOY 

  

	 	13.1	Other than with respect to social security payments if required to be made by the Company or a subsidiary as a result of its choice of the tax treatment of the options pursuant to Section 102, no income or gain
which shall be credited to or which purports to be credited to the grantee as a result of the Plan, shall in any manner be taken into account in the calculation of the basis of the grantee’s entitlements from the Company or any Related Company
or in the calculation of any social welfare right or other rights or benefits arising out of the employee/employer relationship. If, pursuant to any law, the Company or any Related Company, shall be obliged for the purposes of calculation of the
said items to take into account income or gain actually or theoretically credited to the grantee, the grantee shall indemnify the Company or any Related Company, against any expense caused to it in this regard. 

	 	13.2	Nothing in the Plan shall be interpreted as obliging the Company or any Related Company to employ the grantee and nothing in the Plan or any option granted pursuant thereto shall confer upon any grantee any right to
continue in the employment of the Company or any Related Company or restrict the right of the Company or any Related Company to terminate such employment at any time. The grantee shall have no claim whatsoever against the Company or any Related
Company as a result of the termination of his employment, including, without limitation, any claim that such termination causes any options to expire and/or prevents the grantee from exercising the options and/or from receiving or retaining any
shares pursuant to any agreement between him and the Company, or results in any loss due to an early imposition of tax liability pursuant to applicable law. 

  

	14.	ADJUSTMENTS UPON CHANGES IN CAPITALIZATION 

 Notwithstanding any other provisions
of the Plan, the Board shall take such actions, if any, as it deems appropriate for the adjustment of the number and class of shares subject to each unexercised or unvested option and in the option prices in the event of an IPO, changes in the
outstanding share capital of the Company by reason of any stock dividend (bonus shares), stock split, recapitalization, combination, exchange of shares, merger, consolidation, liquidation, split-up, split-off, spin-off or other similar change in
capitalization. In the event of any such event, the Board may make any adjustments it deems appropriate, including in the aggregate number and class of shares available under the Plan, and the Board’s determination in this regard shall be
conclusive. 
  

	15.	TERMINATION AND AMENDMENT 

 Unless the Plan shall theretofore have been terminated
as hereinafter provided, the Plan shall terminate on, and no option shall be granted after, the tenth anniversary of the date the Plan is adopted by the Board. The Board may at any time terminate, modify or amend the Plan in such respects as it
shall deem advisable; provided, however, that the Board may not, without approval by the holders of a majority of the outstanding shares of the Company with voting rights present and voting at a duly held meeting at which a quorum is present,
increase the maximum number of Ordinary Shares as to which options may be granted under the Plan (except by adjustment pursuant to Section 14) or extend the termination date of the Plan. Options granted prior to termination of the Plan may,
subject to the terms of the Plan and any Agreement, be exercised thereafter. No amendment or modification of the Plan may, without the consent of the grantee to whom any option shall theretofore have been granted, adversely affect the rights of such
grantee under such option. 

	16.	EFFECTIVENESS OF THE PLAN 

 The Plan shall become effective as of the date
determined by the Board. 
  

	17.	RELEASE OF THE TRUSTEE AND THE ATTORNEY FROM LIABILITY AND INDEMNIFICATION 

 In no
event shall the Trustee or the Attorney be liable to the Company and/or any grantee under the Plan and/or any third party (including without prejudice to the generality of the aforegoing, to the income tax authorities and any other governmental or
administrative authority), or to a purchaser of shares from any grantee with respect to any act which has been or will be carried out in relation to the Plan, its execution and any matter connected thereto or arising therefrom. The Company will not,
and the grantee will be required to covenant upon signing the Agreement that he will not, make any claim against the Trustee or the Attorney in any manner whatsoever and on any ground whatsoever and they expressly agree that if the Trustee or the
Attorney are sued by them, then the Trustee or the Attorney shall be entitled by virtue of this Section alone to apply to the court for dismissal of the action against them with costs. The Company covenants and agrees that if an action is commenced
by any third party against the Trustee or the Attorney they shall be entitled, without any objection on the Company’s part to join the Company as a third party to any action and a judgment against them will be paid by the Company. 

The Company covenants and the grantee will be required to covenant to indemnify the Trustee and/or the Attorney against any liability in
relation to any claim and/or demand made against the Trustee and/or the Attorney by any person whatsoever, including the tax authorities, in relation to their acts or omissions in connection with the Plan. 

 

	18.	GOVERNING LAW 

 The Plan and all instruments issued thereunder shall be governed
by and construed in accordance with the laws of the State of Israel.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}]]